Login
Israel-Hamas Conflict
Amazon
Floods
Natural Disasters
Social Media
Donald Trump
Artificial Intelligence
Climate Change
European Union
Apple
Basketball
Taxes
Immigration
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Optimum Strategic Communications image

News from Optimum Strategic Communications

Information about Optimum Strategic Communications

Where is Optimum Strategic Communications located?Optimum Strategic Communications's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Optimum Strategic Communications News

Várhelyi Races to Deliver ‘Major Overhaul’ of EU Health Laws in 2025
European Union

Várhelyi Races to Deliver ‘Major Overhaul’ of EU Health Laws in 2025

100% Left coverage: 1 sources
The EU’s health commissioner says there’s “no time to lose” as he lays out a raft of plans in the Life Sciences Strategy for sectors that need urgent assistance.See the Story
New Center in Copenhagen to Pioneer the Future of Protein Design
Medical · Denmark

New Center in Copenhagen to Pioneer the Future of Protein Design

100% Center coverage: 1 sources
Proteins are the workhorses of biology. They perform virtually every important function in living organisms. They store, copy and protect our DNA, digest food to give us energy, and harness this energy to make our cells and muscles work.See the Story
STORM Therapeutics Appoints Veteran Cancer Drug Developer Dr. Eric Martin as Chief Development Officer
England · England

STORM Therapeutics Appoints Veteran Cancer Drug Developer Dr. Eric Martin as Chief Development Officer

100% Center coverage: 1 sources
CAMBRIDGE, England, June 26, 2025 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced the appointment of accomplished cancer biologist Dr. Eric Martin, PhD, as Chief Development Officer…See the Story

Weekly roundup: Dealmaker’s insights, a new CEO, plus… the UK Government’s got a plan! – Optimum Strategic CommunicationsLink to: Can the UK government kick-start the country’s life science industry?Scroll to top

Jacob Falck Hansen appointed as Chief Executive Officer of Vesper Bio Vesper Bio a clinical stage biotech developing an oral therapy for frontotemporal dementia, announces the appointment of Jacob Falck Hansen as Chief Executive Officer. Jacob brings more than 15 years of leadership experience from the pharmaceutical and biotech industry. He is a Partner at […]Dementia · United KingdomRead Article

Breye Therapeutics Reports Completion of Phase 1b for Oral NPDR Therapy

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.See the Story

Jacob Falck Hansen appointed as Chief Executive Officer of Vesper Bio – Optimum Strategic CommunicationsLink to: Weekly roundup: Wins in and out of the clinicScroll to top

Copenhagen, Denmark, 01 July 2025 – Vesper Bio ApS (“Vesper” or “the Company”), a clinical stage biotech developing an oral therapy for frontotemporal dementia, today announces the appointment of Jacob Falck Hansen as Chief Executive Officer (CEO). Jacob Falck Hansen brings more than 15 years of leadership experience from the pharmaceutical and biotech industry. He […]Pharma · DenmarkRead Article

Weekly roundup: Wins in and out of the clinic – Optimum Strategic CommunicationsLink to: Challenge accepted: New funding for ambitious projects within biomanufacturing, cardiometabolic diseases, and artificial intelligenceScroll to top

Curve Therapeutics Co-Founder and CSO Professor Ali Tavassoli awarded the Royal Society of Chemistry’s Interdisciplinary Prize Curve Therapeutics proudly announced that Professor Ali Tavassoli, its Co-Founder and Chief Scientific Officer, has been awarded the Interdisciplinary Prize by the Royal Society of Chemistry in recognition of his brilliance in research and innovation, and contribution to scientific […]Read Article

Challenge accepted: New funding for ambitious projects within biomanufacturing, cardiometabolic diseases, and artificial intelligence – Optimum Strategic CommunicationsLink to: Hot topic: Midsummer is here – winter is comingScroll to top

The 2025 Novo Nordisk Foundation Challenge Programme awards DKK 479 million to nine innovative projects that advance health and sustainability through cooperation between researchers from all over the globe, including Denmark, Sweden, The Netherlands, Belgium, Germany, Australia, and the USA. Read more…Artificial Intelligence · DenmarkRead Article

Curve Therapeutics Co-Founder and CSO Professor Ali Tavassoli awarded the Royal Society of Chemistry’s Interdisciplinary Prize – Optimum Strategic CommunicationsLink to: New Danish research centre to make designed proteins with vast potentialScroll to top

Awarded in recognition of excellence in research and innovation and contribution to scientific progress Reflects the revolutionary potential of Curve’s gene-encoded Microcycle® platform to unlock the therapeutic potential of intracellular targets Southampton, UK, 25 June 2025 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company building a pipeline of innovative cyclic peptide and […]Innovation · SouthamptonRead Article

Weekly roundup: From BIO 2025 to building boards – Optimum Strategic CommunicationsLink to: Hot topic: Should we keep renaming diseases?Scroll to top

Rewind Therapeutics strengthens scientific advisory board with leading international neurology experts as it advances its first-in-class remyelination therapy  Rewind Therapeutics, which is developing first-in-class treatments for demyelination-associated diseases, has appointed four internationally recognised innovators in neurology –  Professors Shiv Saidha, Cristina Granziera, David Leppert, and Roberto Furlan – to its Scientific Advisory Boa…Read Article

Hot topic: Should we keep renaming diseases? – Optimum Strategic CommunicationsLink to: Rewind Therapeutics Strengthens Scientific Advisory Board with Leading International Neurology Experts as it Advances First-in-Class Remyelination TherapyScroll to top

Thursday June 12 was Global Fatty Liver Day. But until 2018 it was known as International NASH Day – NASH being short for ‘non-alcoholic steatohepatitis’. The name of the awareness day was changed to increase awareness of all types of fatty liver disease, as NASH is just one type – a more serious type – […]Professors · LeuvenRead Article

Breaking News Topics Related to Optimum Strategic Communications

Novo Nordisk icon

Novo Nordisk

Startups icon

Startups

United Kingdom icon

United Kingdom

Eli Lilly icon

Eli Lilly

Health icon

Health

Denmark icon

Denmark

Biotech icon

Biotech

England icon

England

United States icon

United States

Medical icon

Medical

News
For You
SearchBlindspotLocal